Nanobiotix (France) Buy Hold or Sell Recommendation
| NANO Stock | EUR 5.54 0.21 3.65% |
Assuming the 90 days trading horizon and your above-average risk tolerance, our recommendation regarding Nanobiotix SA is 'Sell'. Macroaxis provides Nanobiotix buy-hold-or-sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding NANO positions. The advice algorithm takes into account all of Nanobiotix's available fundamental, technical, and predictive indicators you will find on this site. Key drivers impacting Nanobiotix's buy or sell advice are summarized below:
Real Value 4.83 | Hype Value 5.75 | Market Value 5.54 | Naive Value 5.64 |
A buy or sell recommendation provided by Macroaxis is an automated directive regarding whether to purchase or sell Nanobiotix SA given historical horizon and risk tolerance towards Nanobiotix. When Macroaxis issues a 'buy' or 'sell' recommendation for Nanobiotix SA, the advice is generated through an automated system that utilizes algorithms and statistical models.
Nanobiotix |
Execute Nanobiotix Buy or Sell Advice
The Nanobiotix recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Nanobiotix SA. Macroaxis does not own or have any residual interests in Nanobiotix SA or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Nanobiotix's advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Sell
Market Performance | Very Weak | Details | |
Volatility | Slightly risky | Details | |
Hype Condition | Stale | Details | |
Current Valuation | Overvalued | Details | |
Odds Of Distress | Below Average | Details | |
Economic Sensitivity | Follows the market closely | Details | |
Analyst Consensus | Not Available | Details | |
Reporting Quality (M-Score) | Inapplicable | Details |
Nanobiotix Trading Alerts and Improvement Suggestions
| Nanobiotix SA generated a negative expected return over the last 90 days | |
| Nanobiotix SA has high financial leverage indicating that it may have difficulties to generate enough cash to satisfy its financial obligations | |
| The company reported the revenue of 10 K. Net Loss for the year was (47 M) with profit before overhead, payroll, taxes, and interest of 2.65 M. | |
| Nanobiotix SA has accumulated about 36.2 M in cash with (29.87 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.85. |
Nanobiotix Returns Distribution Density
The distribution of Nanobiotix's historical returns is an attempt to chart the uncertainty of Nanobiotix's future price movements. The chart of the probability distribution of Nanobiotix daily returns describes the distribution of returns around its average expected value. We use Nanobiotix SA price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Nanobiotix returns is essential to provide solid investment advice for Nanobiotix.
| Mean Return | -0.21 | Value At Risk | -5.06 | Potential Upside | 4.32 | Standard Deviation | 2.55 |
Return Density |
| Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Nanobiotix historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
Nanobiotix Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Nanobiotix or Healthcare sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Nanobiotix's price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Nanobiotix stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over NYSE Composite | -0.3 | |
β | Beta against NYSE Composite | 0.91 | |
σ | Overall volatility | 2.55 | |
Ir | Information ratio | -0.12 |
Nanobiotix Volatility Alert
Nanobiotix SA exhibits very low volatility with skewness of 0.12 and kurtosis of 1.04. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure Nanobiotix's stock risk against market volatility during both bullish and bearish trends. The higher level of volatility that comes with bear markets can directly impact Nanobiotix's stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different financial instruments as prices fall.Nanobiotix Fundamentals Vs Peers
Comparing Nanobiotix's fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Nanobiotix's direct or indirect competition across all of the common fundamentals between Nanobiotix and the related equities. This way, we can detect undervalued stocks with similar characteristics as Nanobiotix or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of Nanobiotix's fundamental indicators could also be used in its relative valuation, which is a method of valuing Nanobiotix by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare Nanobiotix to competition |
| Fundamentals | Nanobiotix | Peer Average |
| Return On Equity | -1.99 | -0.31 |
| Return On Asset | -0.29 | -0.14 |
| Operating Margin | (17.96) % | (5.51) % |
| Current Valuation | 111.08 M | 16.62 B |
| Shares Outstanding | 34.88 M | 571.82 M |
| Shares Owned By Insiders | 3.78 % | 10.09 % |
| Shares Owned By Institutions | 25.56 % | 39.21 % |
| Price To Earning | (12.17) X | 28.72 X |
| Price To Book | 71.98 X | 9.51 X |
| Price To Sales | 48.04 X | 11.42 X |
| Revenue | 10 K | 9.43 B |
| Gross Profit | 2.65 M | 27.38 B |
| EBITDA | (44.85 M) | 3.9 B |
| Net Income | (47 M) | 570.98 M |
| Cash And Equivalents | 36.2 M | 2.7 B |
| Cash Per Share | 1.85 X | 5.01 X |
| Total Debt | 35.56 M | 5.32 B |
| Debt To Equity | 144.00 % | 48.70 % |
| Current Ratio | 3.68 X | 2.16 X |
| Book Value Per Share | 0.05 X | 1.93 K |
| Cash Flow From Operations | (29.87 M) | 971.22 M |
| Earnings Per Share | (1.20) X | 3.12 X |
| Target Price | 14.9 | |
| Number Of Employees | 103 | 18.84 K |
| Beta | 1.8 | -0.15 |
| Market Capitalization | 115.07 M | 19.03 B |
| Total Asset | 101.77 M | 29.47 B |
| Retained Earnings | (17 M) | 9.33 B |
| Working Capital | 16 M | 1.48 B |
| Current Asset | 23 M | 9.34 B |
| Current Liabilities | 7 M | 7.9 B |
| Z Score | 1.8 | 8.72 |
| Net Asset | 101.77 M |
Nanobiotix Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Nanobiotix . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
About Nanobiotix Buy or Sell Advice
When is the right time to buy or sell Nanobiotix SA? Buying financial instruments such as Nanobiotix Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having Nanobiotix in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Electronics Thematic Idea Now
Electronics
Companies manufacturing electronic appliances and goods. The Electronics theme has 45 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Electronics Theme or any other thematic opportunities.
| View All Next | Launch |
Check out Nanobiotix Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. For information on how to trade Nanobiotix Stock refer to our How to Trade Nanobiotix Stock guide.You can also try the Sign In To Macroaxis module to sign in to explore Macroaxis' wealth optimization platform and fintech modules.
Complementary Tools for Nanobiotix Stock analysis
When running Nanobiotix's price analysis, check to measure Nanobiotix's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Nanobiotix is operating at the current time. Most of Nanobiotix's value examination focuses on studying past and present price action to predict the probability of Nanobiotix's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Nanobiotix's price. Additionally, you may evaluate how the addition of Nanobiotix to your portfolios can decrease your overall portfolio volatility.
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios |